Fruquintinib Provides Meaningful Benefit in Refractory Metastatic CRC

THURSDAY, July 20, 2023 -- For patients with refractory metastatic colorectal cancer, fruquintinib treatment yields a significant and clinically meaningful benefit in terms of overall survival, according to a study published in the July 1 issue of...